ClinVar Miner

Submissions for variant NM_000535.7(PMS2):c.2276-3del

dbSNP: rs587782116
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000130635 SCV000185513 uncertain significance Hereditary cancer-predisposing syndrome 2013-11-14 criteria provided, single submitter clinical testing ​The c.2276-3delT variant is located 3 nucleotides before coding exon 14 of the PMS2 gene. This variant results from a deletion of one nucleotide at position 2276-3. This variant was not reported in population-based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP) and 1000 Genomes Project. To date, this alteration has been detected with an allele frequency of approximately 0.01% (>8,100 alleles tested) in our clinical cohort (includes this individual). This nucleotide position is not well conserved on available sequence alignment. Using the BDGP and ESEfinder splice site prediction tools, this alteration does not have any significant effect on this acceptor splice site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of c.2276-3delT remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.